Artykuły w czasopismach na temat „POTENTIAL INHIBITORS”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „POTENTIAL INHIBITORS”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Lechner, Christian, Maren Flaßhoff, Hannes Falke, Lutz Preu, Nadége Loaëc, Laurent Meijer, Stefan Knapp, Apirat Chaikuad i Conrad Kunick. "[b]-Annulated Halogen-Substituted Indoles as Potential DYRK1A Inhibitors". Molecules 24, nr 22 (13.11.2019): 4090. http://dx.doi.org/10.3390/molecules24224090.
Pełny tekst źródłaSharma, Manish Kumar, Anil Kumar Sharma i S. P. Mathur. "Solanum surrattence as Potential Corrosion Inhibitor". ISRN Corrosion 2012 (28.08.2012): 1–5. http://dx.doi.org/10.5402/2012/907676.
Pełny tekst źródłaSamsudin, Sity Juaeiriah, Nurlidia Binti Mansor, Suriati Sufian i Zakaria B. Man. "The Potential of Garlic Extract as Bio-Inhibitor in Urea Fertilizer". Key Engineering Materials 594-595 (grudzień 2013): 296–300. http://dx.doi.org/10.4028/www.scientific.net/kem.594-595.296.
Pełny tekst źródłaBuolamwini, John K. "Nucleoside Transport Inhibitors: Structure-Activity Relationships and Potential Therapeutic Applications". Current Medicinal Chemistry 4, nr 1 (luty 1997): 35–66. http://dx.doi.org/10.2174/0929867304666220309201038.
Pełny tekst źródłaChen, Xingchen, Darren Leahy, Jessica Van Haeften, Perry Hartfield, Peter J. Prentis, Chloé A. van der Burg, Joachim M. Surm i in. "A Versatile and Robust Serine Protease Inhibitor Scaffold from Actinia tenebrosa". Marine Drugs 17, nr 12 (12.12.2019): 701. http://dx.doi.org/10.3390/md17120701.
Pełny tekst źródłaŽbulj, Katarina, Gordana Bilić, Lidia Hrnčević i Katarina Simon. "Potential of using plant extracts as green corrosion inhibitors in the petroleum industry". Rudarsko-geološko-naftni zbornik 36, nr 5 (2021): 132–39. http://dx.doi.org/10.17794/rgn.2021.5.12.
Pełny tekst źródłaSerio, Rosa, Flavia Mulé i Alessandra Postorino. "Noradrenergic, noncholinergic inhibitory junction potentials in rat proximal colon: role of nitric oxide". Canadian Journal of Physiology and Pharmacology 73, nr 1 (1.01.1995): 79–84. http://dx.doi.org/10.1139/y95-011.
Pełny tekst źródłaSliskovic, Drago R., i Bharat K. Trivedi. "ACAT Inhibitors: Potential Anti-atherosclerotic Agents". Current Medicinal Chemistry 1, nr 3 (październik 1994): 204–55. http://dx.doi.org/10.2174/092986730103220214163743.
Pełny tekst źródłaRobina, Inmaculada, Antonio Moreno-Vargas, Ana Carmona i Pierre Vogel. "Glycosidase Inhibitors as Potential HIV Entry Inhibitors?" Current Drug Metabolism 5, nr 4 (1.08.2004): 329–61. http://dx.doi.org/10.2174/1389200043335513.
Pełny tekst źródłaEvans, Tarra, i Ursula Matulonis. "PARP inhibitors in ovarian cancer: evidence, experience and clinical potential". Therapeutic Advances in Medical Oncology 9, nr 4 (3.02.2017): 253–67. http://dx.doi.org/10.1177/1758834016687254.
Pełny tekst źródłaShamkh, Israa M., Mohammed Al-Majidi, Ahmed Hassen Shntaif, Peter Tan Deng Kai, Ngoc Nh-Pham, Ishrat Rahman, Dalia Hamza i in. "Nontoxic and Naturally Occurring Active Compounds as Potential Inhibitors of Biological Targets in Liriomyza trifolii". International Journal of Molecular Sciences 23, nr 21 (24.10.2022): 12791. http://dx.doi.org/10.3390/ijms232112791.
Pełny tekst źródłaTábi, Tamás, László Vécsei, Moussa B. Youdim, Peter Riederer i Éva Szökő. "Selegiline: a molecule with innovative potential". Journal of Neural Transmission 127, nr 5 (27.09.2019): 831–42. http://dx.doi.org/10.1007/s00702-019-02082-0.
Pełny tekst źródłaBrown, Nancy J. "Review: Therapeutic potential of plasminogen activator inhibitor-1 inhibitors". Therapeutic Advances in Cardiovascular Disease 4, nr 5 (26.07.2010): 315–24. http://dx.doi.org/10.1177/1753944710379126.
Pełny tekst źródłaHonisch, Claudia, Matteo Gazziero, Roberto Dallocchio, Alessandro Dessì, Davide Fabbri, Maria Antonietta Dettori, Giovanna Delogu i Paolo Ruzza. "Antamanide Analogs as Potential Inhibitors of Tyrosinase". International Journal of Molecular Sciences 23, nr 11 (2.06.2022): 6240. http://dx.doi.org/10.3390/ijms23116240.
Pełny tekst źródłaMcFadden, Karyn, Patricia Fletcher, Fiorella Rossi, Kantharaju, Muddagowda Umashankara, Vanessa Pirrone, Srivats Rajagopal i in. "Antiviral Breadth and Combination Potential of Peptide Triazole HIV-1 Entry Inhibitors". Antimicrobial Agents and Chemotherapy 56, nr 2 (14.11.2011): 1073–80. http://dx.doi.org/10.1128/aac.05555-11.
Pełny tekst źródłaYuasa, Hideya, Masayuki Izumi i Hironobu Hashimoto. "Thiasugars: Potential Glycosidase Inhibitors". Current Topics in Medicinal Chemistry 9, nr 1 (1.01.2009): 76–86. http://dx.doi.org/10.2174/156802609787354270.
Pełny tekst źródłaGao, Yinghong, Stephen P. Davies, Martin Augustin, Anna Woodward, Umesh A. Patel, Robert Kovelman i Kevin J. Harvey. "A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery". Biochemical Journal 451, nr 2 (28.03.2013): 313–28. http://dx.doi.org/10.1042/bj20121418.
Pełny tekst źródłaVenkatachalam, Prerana, i Varalakshmi Kilingar Nadumane. "Purification and Characterization of a Protease Inhibitor with Anticancer Potential from Bacillus endophyticus JUPR15". Current Cancer Therapy Reviews 15, nr 1 (22.02.2019): 74–82. http://dx.doi.org/10.2174/1573394714666180321150605.
Pełny tekst źródłaZhang, Xiaoyin, Yue He, Zhanbo Xiong, Min Li, Ming Li, Nan Zheng, Shengguo Zhao i Jiaqi Wang. "Chelerythrine Chloride: A Potential Rumen Microbial Urease Inhibitor Screened by Targeting UreG". International Journal of Molecular Sciences 22, nr 15 (30.07.2021): 8212. http://dx.doi.org/10.3390/ijms22158212.
Pełny tekst źródłaSasaki-Tanaka, Reina, Kalyan C. Nagulapalli Venkata, Hiroaki Okamoto, Mitsuhiko Moriyama i Tatsuo Kanda. "Evaluation of Potential Anti-Hepatitis A Virus 3C Protease Inhibitors Using Molecular Docking". International Journal of Molecular Sciences 23, nr 11 (27.05.2022): 6044. http://dx.doi.org/10.3390/ijms23116044.
Pełny tekst źródłaHayashi, Masayasu, Yoshikane Kikushige, Takuya Harada, Toshihiro Miyamoto, Takahiro Maeda i Koichi Akashi. "Somatic Mutations Potentiating RAS-MAPK Signaling Confer Resistant Potential Against FLT3-Inhibitors to Acute Myelogenous Leukemia". Blood 134, Supplement_1 (13.11.2019): 910. http://dx.doi.org/10.1182/blood-2019-130694.
Pełny tekst źródłaSon, Yun Gon, Ju Yeon Kim, Jae Yeon Park, Kwang Dong Kim, Ki Hun Park i Jeong Yoon Kim. "Inhibitory Potential of Quercetin Derivatives Isolated from the Aerial Parts of Siegesbeckia pubescens Makino against Bacterial Neuraminidase". Molecules 28, nr 14 (12.07.2023): 5365. http://dx.doi.org/10.3390/molecules28145365.
Pełny tekst źródłaKhunluck, Tueanjai, Veerapol Kukongviriyapan, Laddawan Senggunprai, Wutthipong Duangarsong i Auemduan Prawan. "The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells". Integrative Cancer Therapies 18 (25.12.2018): 153473541882044. http://dx.doi.org/10.1177/1534735418820444.
Pełny tekst źródłaKurihara, Hideyuki, i Kazuki Kujira. "Phlorotannins Derived From the Brown Alga Colpomenia bullosa as Tyrosinase Inhibitors". Natural Product Communications 16, nr 7 (lipiec 2021): 1934578X2110213. http://dx.doi.org/10.1177/1934578x211021317.
Pełny tekst źródłaHabash, Maha, Sami Alshakhshir, Shady Awwad i Mahmoud Abu-Samak. "The discovery of potential tumor necrosis factor alpha converting enzyme inhibitors via implementation of K Nearest Neighbor QSAR analysis". Pharmacia 70, nr 2 (12.04.2023): 247–61. http://dx.doi.org/10.3897/pharmacia.70.e96423.
Pełny tekst źródłaKopecký, Jindřich. "New potential checkpoint inhibitors in cancer therapy". Onkologie 16, nr 3 (16.05.2022): 115–17. http://dx.doi.org/10.36290/xon.2022.022.
Pełny tekst źródłaJeng, Arco Y., Paul Mulder, Aij-Lie Kwan i Bruno Battistini. "Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications". Canadian Journal of Physiology and Pharmacology 80, nr 5 (1.05.2002): 440–49. http://dx.doi.org/10.1139/y02-025.
Pełny tekst źródłaHan, Yoo Kyong, Ji Sun Lee, Seo Young Yang, Ki Yong Lee i Young Ho Kim. "In Vitro and In Silico Studies of Soluble Epoxide Hydrolase Inhibitors from the Roots of Lycopus lucidus". Plants 10, nr 2 (13.02.2021): 356. http://dx.doi.org/10.3390/plants10020356.
Pełny tekst źródłaMia, Md Abdur Rashid, Qamar Uddin Ahmed, Sahena Ferdosh, Abul Bashar Mohammed Helaluddin, Md Shihabul Awal, Murni Nazira Sarian, Md Zaidul Islam Sarker i Zainul Amiruddin Zakaria. "In Vitro, In Silico and Network Pharmacology Mechanistic Approach to Investigate the α-Glucosidase Inhibitors Identified by Q-ToF-LCMS from Phaleria macrocarpa Fruit Subcritical CO2 Extract". Metabolites 12, nr 12 (15.12.2022): 1267. http://dx.doi.org/10.3390/metabo12121267.
Pełny tekst źródłaSattler, Martin, Isa Mambetsariev, Jeremy Fricke, Tingting Tan, Sariah Liu, Nagarajan Vaidehi, Evan Pisick i in. "A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine". Journal of Clinical Medicine 12, nr 5 (1.03.2023): 1936. http://dx.doi.org/10.3390/jcm12051936.
Pełny tekst źródłaKondža, Martin, Mirza Bojić, Ivona Tomić, Željan Maleš, Valentina Rezić i Ivan Ćavar. "Characterization of the CYP3A4 Enzyme Inhibition Potential of Selected Flavonoids". Molecules 26, nr 10 (19.05.2021): 3018. http://dx.doi.org/10.3390/molecules26103018.
Pełny tekst źródłaColland, Frédéric. "The therapeutic potential of deubiquitinating enzyme inhibitors". Biochemical Society Transactions 38, nr 1 (19.01.2010): 137–43. http://dx.doi.org/10.1042/bst0380137.
Pełny tekst źródłaPertwee, Roger G. "Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications". Proceedings of the Nutrition Society 73, nr 1 (18.10.2013): 96–105. http://dx.doi.org/10.1017/s0029665113003649.
Pełny tekst źródłaSanni, Omotayo, Samuel Ayodele Iwarere i Michael Olawale Daramola. "Investigation of Eggshell Agro-Industrial Waste as a Potential Corrosion Inhibitor for Mild Steel in Oil and Gas Industry". Sustainability 15, nr 7 (3.04.2023): 6155. http://dx.doi.org/10.3390/su15076155.
Pełny tekst źródłaBasak, Debasish, David Gamez i Subrata Deb. "SGLT2 Inhibitors as Potential Anticancer Agents". Biomedicines 11, nr 7 (30.06.2023): 1867. http://dx.doi.org/10.3390/biomedicines11071867.
Pełny tekst źródłaKholilah, Tsaniyah, Nashi Widodo i Nia Kurniawan. "in silico Study Reveals Potential Docking Sites of δ 2-isoxazolines derivates for Inhibiting Russell’s Viper PLA2 Toxin". Journal of Tropical Life Science 11, nr 1 (3.02.2021): 45–51. http://dx.doi.org/10.11594/jtls.11.01.06.
Pełny tekst źródłaALIAS, ZAZALI, i NORA ASYIKIN RAMLI. "PURIFICATION AND PARTIAL CHARACTERISATION OF A PROTEASE INHIBITOR FROM Mimosa diplotricha". Malaysian Applied Biology 51, nr 4 (31.10.2022): 169–75. http://dx.doi.org/10.55230/mabjournal.v51i4.26.
Pełny tekst źródłaHan, Seungmin, Kwang Suk Lim, Brody J. Blackburn, Jina Yun, Charles W. Putnam, David A. Bull i Young-Wook Won. "The Potential of Topoisomerase Inhibitor-Based Antibody–Drug Conjugates". Pharmaceutics 14, nr 8 (16.08.2022): 1707. http://dx.doi.org/10.3390/pharmaceutics14081707.
Pełny tekst źródłaZhang, Yi-Lin, Yong Yan, Xue-Jun Wang i Ke-Wu Yang. "Synthesis and Bioactivity of Thiazolethioacetamides as Potential Metallo-β-Lactamase Inhibitors". Antibiotics 9, nr 3 (26.02.2020): 99. http://dx.doi.org/10.3390/antibiotics9030099.
Pełny tekst źródłaChu, Ming-Jie, Wei Wang, Zi-Li Ren, Hao Liu, Xiang Cheng, Kai Mo, Li Wang, Feng Tang i Xian-Hai Lv. "Discovery of Novel Triazole-Containing Pyrazole Ester Derivatives as Potential Antibacterial Agents". Molecules 24, nr 7 (3.04.2019): 1311. http://dx.doi.org/10.3390/molecules24071311.
Pełny tekst źródłaR. Somani, Rakesh, i Mayuri H. Patel. "Telomerase Inhibitors: Potential Anticancer Agents". Mini-Reviews in Organic Chemistry 13, nr 1 (4.03.2016): 49–61. http://dx.doi.org/10.2174/1570193x13666160225000624.
Pełny tekst źródłaElias, Daniel, i Henrik J. Ditzel. "The potential of Src inhibitors". Aging 7, nr 10 (2.10.2015): 734–35. http://dx.doi.org/10.18632/aging.100821.
Pełny tekst źródłaLazarevic-Pasti, Tamara, Andreja Leskovac i Vesna Vasic. "Myeloperoxidase Inhibitors as Potential Drugs". Current Drug Metabolism 16, nr 3 (12.08.2015): 168–90. http://dx.doi.org/10.2174/138920021603150812120640.
Pełny tekst źródłaDerler, Isabella, Reinhard Fritsch, Rainer Schindl i Christoph Romanin. "CRAC inhibitors: identification and potential". Expert Opinion on Drug Discovery 3, nr 7 (23.06.2008): 787–800. http://dx.doi.org/10.1517/17460441.3.7.787.
Pełny tekst źródłaVerstovsek, Srdan. "Therapeutic Potential of JAK2 Inhibitors". Journal of OncoPathology 1, nr 1 (1.04.2013): 76–79. http://dx.doi.org/10.13032/tjop.2052-5931.100024.
Pełny tekst źródłaMathe, Christophe, i Vasu Nair. "Potential Inhibitors of HIV Integrase". Nucleosides and Nucleotides 18, nr 4-5 (kwiecień 1999): 681–82. http://dx.doi.org/10.1080/15257779908041539.
Pełny tekst źródłaLOBL, T. J., H. E. RENIS, R. M. EPAND, L. L. MAGGIORA i M. W. WATHEN. "Peptides as potential virus inhibitors". International Journal of Peptide and Protein Research 32, nr 5 (12.01.2009): 326–30. http://dx.doi.org/10.1111/j.1399-3011.1988.tb01267.x.
Pełny tekst źródłaPerry, Martin J., i Gerald A. Higgs. "Chemotherapeutic potential of phosphodiesterase inhibitors". Current Opinion in Chemical Biology 2, nr 4 (styczeń 1998): 472–81. http://dx.doi.org/10.1016/s1367-5931(98)80123-3.
Pełny tekst źródłaBedaiwy, Mohamed A., Noha A. Mousa i Robert F. Casper. "Aromatase Inhibitors: Potential Reproductive Implications". Journal of Minimally Invasive Gynecology 16, nr 5 (wrzesień 2009): 533–39. http://dx.doi.org/10.1016/j.jmig.2009.05.009.
Pełny tekst źródłaLavin, Martin F., i Abrey J. Yeo. "Clinical potential of ATM inhibitors". Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 821 (maj 2020): 111695. http://dx.doi.org/10.1016/j.mrfmmm.2020.111695.
Pełny tekst źródła